During the past decade, Mile High Research Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mile High Research Center" #1 sponsor was "Eisai Inc." with 4 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Athira Pharma" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mile High Research Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "Alzheimer's Association" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mile High Research Center" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (7 trials), "Migraine" (2 trials), "Parkinson's Disease" (2 trials) and "Refractory Partial Seizures" (2 trials). Many other conditions were trialed in "Mile High Research Center" in a lesser frequency.

Most popular intervention types in "Mile High Research Center" are "Drug" (29 trials), "Device" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "ATH-1017" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "E2007 (perampanel)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mile High Research Center" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Mile High Research Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Mile High Research Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Mile High Research Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".